Sidley advised R-Bridge Healthcare Fund (RBF) on the deal. Mourant advised Natixis Corporate & Investment Banking’s Hong Kong Branch. Reed Smith has advised leading global financial...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Yisheng Biopharma Co., Ltd. on the deal, while Sidley Austin LLP and Maples and Calder advised R-Bridge Healthcare Fund. Yisheng Biopharma Co.,...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised AstraZeneca China on the deal. AstraZeneca China announced a strategic collaboration with Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences). AstraZeneca China will be...
You must be a Standard 1 Year member to access this content.
